Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTSO Cytosorbents Corporation

未开盘 09-23 16:00:00 EDT

4.91

-0.41

-7.71%

盘后4.91

+0.000.00%

19:30 EDT

最高5.36	最低4.90	成交量6,107
今开5.25	昨收5.32	日振幅8.74%
总市值1,542万	流通市值1,276万	总股本314.02万
成交额3.15万	换手率0.24%	流通股本259.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTSO","market":"US","secType":"STK","nameCN":"Cytosorbents Corporation","latestPrice":4.91,"timestamp":1790193600000,"preClose":5.32,"halted":0,"volume":6107,"hourTrading":{"tag":"盘后","latestPrice":4.91,"preClose":4.91,"latestTime":"19:30 EDT","volume":51,"amount":247.78,"timestamp":1790206200502,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07706766917293235,"floatShares":2598409,"shares":3140215,"eps":-5.80188,"marketStatus":"未开盘","change":-0.41,"latestTime":"09-23 16:00:00 EDT","open":5.25,"high":5.36,"low":4.895,"amount":31499.000331900002,"amplitude":0.087406,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.80188,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1790236800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.32,"preHourTrading":{"tag":"盘前","latestPrice":5.48,"preClose":5.32,"latestTime":"07:07 EDT","volume":30,"amount":164.4,"timestamp":1790161658250,"change":0.16,"changeRate":0.030075,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.91,"preClose":4.91,"latestTime":"19:30 EDT","volume":51,"amount":247.78,"timestamp":1790206200502,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.756379,"impliedVol":1.3682,"impliedVolPercentile":0.9958},"requestUrl":"/m/hq/s/CTSO","defaultTab":"news","newsList":[{"id":"1193551708","title":"Cytosorbents公司：Cytosorb在冠状动脉搭桥术患者中应用与严重出血风险相对减少37%相关","url":"https://stock-news.laohu8.com/highlight/detail?id=1193551708","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193551708?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:32","pubTimestamp":1788348763,"startTime":"0","endTime":"0","summary":"Cytosorbents Corporation（Cytosorbents）宣布，其Cytosorb设备在冠状动脉旁路移植术（CABG）患者中的使用，与严重出血事件的相对减少37%存在关联。这一数据凸显了该技术在心脏外科手术中可能带来的临床获益，尤其是在改善患者预后方面。Cytosorbents的这项发现，为Cytosorb在围手术期管理中的应用提供了新的证据支持，有望在未来进一步推动其在临床实践中的广泛采用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146599147","title":"Cytosorbents获准延长180天以恢复纳斯达克最低股价合规要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1146599147","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146599147?lang=zh_cn&edition=full","pubTime":"2026-04-02 19:03","pubTimestamp":1775127793,"startTime":"0","endTime":"0","summary":"根据提交至美国证券交易委员会（SEC）的文件显示，Cytosorbents Corporation（简称Cytosorbents）已于4月1日获得纳斯达克交易所的批准，将其恢复最低股价合规的期限延长180天。此次延期为公司提供了更多时间，以满足纳斯达克上市规则中关于股价必须连续10个交易日不低于1美元的要求。若未能在此期间内达标，公司可能面临退市风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111993033","title":"Cytosorbents公司考虑实施反向拆股等方案以恢复合规——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1111993033","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111993033?lang=zh_cn&edition=full","pubTime":"2026-04-02 19:03","pubTimestamp":1775127792,"startTime":"0","endTime":"0","summary":"Cytosorbents公司（Cytosorbents Corporation）近日向美国证券交易委员会提交的文件显示，该公司正积极考虑包括反向股票拆分在内的多种策略选项，旨在重新达到交易所的上市合规要求。这一举措凸显了公司为维持上市地位、提升股价表现所采取的必要行动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512480345","title":"Cytosorbents Corporation股价飙升10.17% 市值涨284.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512480345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512480345?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:33","pubTimestamp":1739986437,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时33分，Cytosorbents Corporation股票出现异动，股价急速拉升10.17%。截至发稿，该股报1.30美元/股，成交量4.6002万股，换手率0.08%，振幅3.81%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.49%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200133579628eae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200133579628eae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165553","title":"Cytosorbents Corporation盘中异动 早盘快速跳水10.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165553?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889138,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Cytosorbents Corporation股票出现波动，股价大幅跳水10.77%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.85%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232189889fcbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232189889fcbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511941706","title":"Cytosorbents Corporation盘中异动 早盘大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511941706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511941706?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:07","pubTimestamp":1739545633,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时07分，Cytosorbents Corporation股票出现波动，股价大幅跳水5.34%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214230713abcf0ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214230713abcf0ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511658385","title":"Cytosorbents Corporation盘中异动 股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511658385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511658385?lang=zh_cn&edition=full","pubTime":"2025-02-13 01:48","pubTimestamp":1739382487,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日01时48分，Cytosorbents Corporation股票出现波动，股价急速上涨5.64%。截至发稿，该股报1.13美元/股，成交量5.3507万股，换手率0.09%，振幅4.67%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.46%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213014808abcc88d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213014808abcc88d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510335029","title":"Cytosorbents Corporation盘中异动 早盘大幅上涨5.04%报1.040美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510335029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510335029?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:27","pubTimestamp":1739287662,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时27分，Cytosorbents Corporation股票出现异动，股价急速拉升5.04%。截至发稿，该股报1.040美元/股，成交量3.5116万股，换手率0.06%，振幅6.06%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.26%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232742961f52bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232742961f52bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509208263","title":"Cytosorbents Corporation盘中异动 早盘股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509208263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509208263?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:43","pubTimestamp":1738856593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时43分，Cytosorbents Corporation股票出现异动，股价大幅上涨5.94%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.19%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234313abc4e4a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234313abc4e4a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503916421","title":"Cytosorbents Corporation盘中异动 急速跳水5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503916421?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:11","pubTimestamp":1737040314,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时11分，Cytosorbents Corporation股票出现异动，股价大幅跳水5.56%。截至发稿，该股报1.02美元/股，成交量3.1816万股，换手率0.06%，振幅5.09%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.93%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231154abad5983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231154abad5983&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503776615","title":"Cytosorbents Corporation盘中异动 股价大涨5.71%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503776615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503776615?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:36","pubTimestamp":1736865380,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时36分，Cytosorbents Corporation股票出现波动，股价大幅拉升5.71%。截至发稿，该股报1.11美元/股，成交量1.4859万股，换手率0.03%，振幅2.28%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.70%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223620a221b9b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223620a221b9b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503801586","title":"Cytosorbents Corporation盘中异动 早盘股价大涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503801586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503801586?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:57","pubTimestamp":1736780242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时57分，Cytosorbents Corporation股票出现异动，股价快速拉升6.64%。截至发稿，该股报1.000美元/股，成交量2.1137万股，换手率0.04%，振幅6.40%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.27%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132257229864dad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132257229864dad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502898777","title":"Cytosorbents Corporation盘中异动 快速跳水5.14%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502898777?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:20","pubTimestamp":1736522415,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时20分，Cytosorbents Corporation股票出现异动，股价快速跳水5.14%。截至发稿，该股报0.920美元/股，成交量2.1578万股，换手率0.04%，振幅5.15%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.34%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110232015aba60f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110232015aba60f73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501783923","title":"Cytosorbents Corporation盘中异动 早盘急速下跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501783923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501783923?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:02","pubTimestamp":1736262159,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时02分，Cytosorbents Corporation股票出现波动，股价大幅下跌5.76%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.13%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107230239a218eebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107230239a218eebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501230165","title":"Cytosorbents Corporation盘中异动 股价大涨7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501230165?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:31","pubTimestamp":1736173913,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时31分，Cytosorbents Corporation股票出现波动，股价快速上涨7.84%。截至发稿，该股报1.010美元/股，成交量18.4445万股，换手率0.34%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.13%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223154985ce758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223154985ce758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500142061","title":"Cytosorbents Corporation盘中异动 早盘股价大跌5.43%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500142061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500142061?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:30","pubTimestamp":1735914641,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时30分，Cytosorbents Corporation股票出现异动，股价大幅跳水5.43%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Quantum-Si Incorporated、Strata Skin Sciences, Inc.、Envveno Medical Corporation涨幅较大，Quantum-Si Incorporated、Cytosorbents Corporation、Adagio Medical Holdings, Inc较为活跃，换手率分别为18.59%、9.18%、1.18%，振幅较大的相关个股有Ainos, Inc.、阿尔法泰克、古特拉，振幅分别为4.00%、2.10%、1.79%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223042985a3d4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223042985a3d4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495615744","title":"Cytosorbents Corporation盘中异动 股价大涨5.56%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495615744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495615744?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:47","pubTimestamp":1735656422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时47分，Cytosorbents Corporation股票出现波动，股价急速上涨5.56%。截至发稿，该股报0.950美元/股，成交量1.4259万股，换手率0.03%，振幅5.56%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.39%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224702a2108e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224702a2108e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494670408","title":"Cytosorbents Corporation盘中异动 股价大涨5.23%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494670408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494670408?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:37","pubTimestamp":1735231031,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日00时37分，Cytosorbents Corporation股票出现异动，股价急速上涨5.23%。截至发稿，该股报0.940美元/股，成交量5.0478万股，换手率0.09%，振幅7.38%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.07%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227003711a20aafdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227003711a20aafdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493087928","title":"Cytosorbents Corporation盘中异动 早盘急速拉升9.72%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493087928?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:32","pubTimestamp":1735050779,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时32分，Cytosorbents Corporation股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.16%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493977347","title":"Cytosorbents Corporation盘中异动 快速跳水6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493977347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493977347?lang=zh_cn&edition=full","pubTime":"2024-12-24 03:56","pubTimestamp":1734983806,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日03时56分，Cytosorbents Corporation股票出现异动，股价大幅下挫6.24%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.05%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224035646984d3f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224035646984d3f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytosorbents.com","stockEarnings":[{"period":"1week","weight":-0.1431},{"period":"1month","weight":-0.3368},{"period":"3month","weight":-0.4663},{"period":"6month","weight":-0.586},{"period":"1year","weight":-0.7445},{"period":"ytd","weight":-0.6159}],"compareEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.0057},{"period":"3month","weight":0.0456},{"period":"6month","weight":0.2109},{"period":"1year","weight":0.1577},{"period":"ytd","weight":0.126}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cytosorbents Corporation于2002年4月25日在内华达州注册成立。该公司是通过血液净化治疗重症监护室和心脏手术中危及生命的疾病的领导者。该公司的专有血液净化技术基于生物相容性、高度多孔的聚合物珠，可以通过孔隙捕获和表面吸附从血液和其他体液中主动去除有毒物质。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.078517},{"month":2,"riseRate":0.833333,"avgChangeRate":0.111619},{"month":3,"riseRate":0.25,"avgChangeRate":-0.054295},{"month":4,"riseRate":0.583333,"avgChangeRate":-0.057309},{"month":5,"riseRate":0.333333,"avgChangeRate":0.000674},{"month":6,"riseRate":0.583333,"avgChangeRate":0.036225},{"month":7,"riseRate":0.666667,"avgChangeRate":0.063227},{"month":8,"riseRate":0.5,"avgChangeRate":-0.033731},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.018276},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.071309},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.06246},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.086212}],"exchange":"NASDAQ","name":"Cytosorbents Corporation","nameEN":"Cytosorbents"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cytosorbents Corporation,CTSO,Cytosorbents Corporation股票,Cytosorbents Corporation股票老虎,Cytosorbents Corporation股票老虎国际,Cytosorbents Corporation行情,Cytosorbents Corporation股票行情,Cytosorbents Corporation股价,Cytosorbents Corporation股市,Cytosorbents Corporation股票价格,Cytosorbents Corporation股票交易,Cytosorbents Corporation股票购买,Cytosorbents Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}